Upload
voliem
View
220
Download
3
Embed Size (px)
Citation preview
Transformational Strategy: Renewable n-Butanol For Biorefineries
© Green Biologics Inc. 2013 Private and Confidential
Contact:[email protected]
June 18, 2013
Strategic Pillars Reflect Our Approach to BusinessStrategic Pillars Reflect Our Approach to Business
Know more about our business partners and how to address their priorities
Extract more value from feedstocks handled and processed
Innovate and optimize our business and performance in p prenewable chemicals
© Green Biologics Inc. 2013 Private and Confidential 2© Green Biologics Inc. 2013 Private and Confidential
Global Market PresenceGlobal Market Presence
Abingdon, EnglandHQ Office/Labs/PilotColumbus, OH
Pilot Plant/Lab
Jiangsu, China
Jilin, China
Pilot Plant/Lab
B il
US ethanol retrofit/bolt-on
India
Guangxi, ChinaDemo Plant, IA(partner facility)
Brazil India
Richmond, VABus. Office
© Green Biologics Inc. 2013 Private and Confidential 3© Green Biologics Inc. 2013 Private and Confidential
Transforming Established TechnologyTransforming Established Technology
The Clostridia ABE process was developed in Britain in early 20th century by Chaim Weizmann later thein early 20th century by Chaim Weizmann, later the first president of Israel
Large and growing global industry until the 40s when oil prices droppedp pp
Used commercially in Russia and South Africa until the 1980s
A well-understood and reliable commercial process Fermenters in Toronto ABE plant, 1917Picture courtesy of City of Toronto archivesp
Today the GBL transformed process is competitive with petroleum-derived butanol.
Picture courtesy of City of Toronto archives
© Green Biologics Inc. 2013 Private and Confidential 4© Green Biologics Inc. 2013 Private and Confidential
South African ABE plant, circa 1950
Commercially Focused Technology: Flexible Bioprocessing
Fermentation & Solvent Recovery
Molasses
Feedstocks Hydrolysis
Commercially Focused Technology: Flexible Bioprocessing
Products
Glycerine
Hemi-cellulose Butanol
Acetone
Proprietary seed system
H2hydrogen capture
SaccharificationCorn Starch
Hydrolysis
EthanolAdvanced Fermentation
seed system
Oppp
Sorted MSW Pre - treatment Hydrogen
1-Butene
Wood
Corn stover
Hi h l
Butyric Acid
Advanced Solvent Recovery
BEST™
B
© Green Biologics Inc. 2013 Private and Confidential 5© Green Biologics Inc. 2013 Private and Confidential
Existing Technology
Under Development
High value chemicals C4 platform
Bagasse
Competitive Advantage: Leader in C4 RenewablesCompetitive Advantage: Leader in C4 Renewables
Implementation Positioning and Feedstock FlexibilityTechnology Platform
Process engineering designs
Strategy
High value product
Performance
Cellulosic feedstock pre-
&
Feedstock Flexibility
Extensive microbial culture collection
Technology Platform
for “bolt on” & ethanol retrofit projects
Sugar/pulp mill bolt-
Low cost producer
Capital efficient Drop-in chemical
treatment & hydrolysis
Including both C5 and C6 sugarsP id
(>300 strains) Leading expertise
to improve microbial strain
on and retrofit Enables high return,
low capex solutions Know-how from
Technology demonstration at commercial scale
Sustainable /
Proven on wide range of cellulosic feedstocks (stover, bagasse, MSW d l
performance Advanced
continuous fermentation
working across global customer base
favorable LCA MSW, wood, pulp waste)
process BEST™ solvent
recovery
© Green Biologics Inc. 2013 Private and Confidential 6© Green Biologics Inc. 2013 Private and Confidential
Market Opportunity: Large and Growing MarketMarket Opportunity: Large and Growing Market
Large and Growing Market Product Pipeline& Markets
Building block chemical in $85 billion paints, coatings, inks, and adhesives
Cellulosic feedstocks $270 Billion
Competitive price
Sustainable & favorable LCA
Advanced biofuel for $2 trillion global $40 Billion
$140 Billion
$10 BillionExisting Market
gtransport fuels market
Core technology program positions GBL well in fuels
$5 Billion $5 Billion
$
n-Butanol(Core Market)
Acetone & Derivatives
Butene, Butadiene, & IPA
Synthetic Oils & Biofuels
Jet Fuel
© Green Biologics Inc. 2013 Private and Confidential 7© Green Biologics Inc. 2013 Private and Confidential
Source: Management Presentation, Wall Street, Internal Research & Industry Research.
n-Butanol End Uses
High growth opportunities in acrylates and acetates
n Butanol End Uses
(AGR 1.4%)
Global demand estimated at 3.4mT p.a. growing at 4.4% p.a. short term
China demand is growing at 9% p.a.; will h 40% f l b l d d b 2020
Solvent15%
Other5%
reach 40% of global demand by 2020
Targeting collaborations with both renewable and existing C4 derivatives producers
Acrylate41%
Glycol Ethers
9%
(AGR 5.5%)
(AGR 2.8%)
(AGR 2.7%)
producers
Primary end market is $85 billion global paints, coatings, inks and adhesives industry
Acetate30%
(AGR 3.9%)
industry
Major downstream customers are demanding renewable raw materials
© Green Biologics Inc. 2013 Private and Confidential 8© Green Biologics Inc. 2013 Private and Confidential
Source: IHS
Flexible Feedstocks
Use of C5 sugars key to superior performance
Flexible Feedstocks
Typical Cellulosic Composition
performance
GBL’s organisms can utilize diverse cellulosic feedstocks C6 Sugars
C5 Sugars
Molasses: Corn Woody Sugar Cane Municipal Solid
Product Yield on Sugars Fed (%)
Molasses:benchmark
Corn Stover
Woody Biomass
Sugar Cane Bagasse
35% 37% 39% 39%
Municipal Solid Waste
35%38%35% 37% 39% 39% 35%38%
© Green Biologics Inc. 2013 Private and Confidential 9© Green Biologics Inc. 2013 Private and Confidential
Commercial Programs Supported by Intellectual Propertyg pp y p y
Technology assets (microbial culture collection)
Patents (core IP) Patents (core IP)
Know how (methods/skills/expertise)
Gas recovery
StrainDevelopment
Process Development
Feedstock Hydrolysis
Design &Engineering
Superior Microbes
BESTTM
Advanced
recoverycontrol
barcode
Water recycle
Pre-treatment Retrofit
Culture
Genetic engineering &
synthetic biology
Fermentation
Product recovery
Chemical mutagenesis
recycleHydrolysis New
BuildCollection
ContinuousBEST1000
© Green Biologics Inc. 2013 Private and Confidential 10© Green Biologics Inc. 2013 Private and Confidential
Integrated Technology AdvancementIntegrated Technology Advancement
Three Parallel Programs for Continuous Cost Reduction
Process DevelopmentStrain Development FeedstocksDeveloping and optimizing high
performance processes including seed development, fermentation, product
recovery, water use
pEnlarging and probing the culture
collectionGenerating improved strains
FeedstocksScreening feedstocks and feedstock
conversion technologies for integration into the GBL production process
Integrated renewable n-
butanol production platform
© Green Biologics Inc. 2013 Private and Confidential 11© Green Biologics Inc. 2013 Private and Confidential
North America Ethanol OptionsNorth America Ethanol Options
Bolt on to existing ethanol asset Ease of deployment Value added to existing asset Transformation to a biorefining complex
Phase 2 addition of cellulose conversion Phase 2 addition of cellulose conversion Fermentation including both C5 and C6 sugars Proven on wide range of cellulosic feedstocks Ability to operate on cellulose or original bolt on corn mashAbility to operate on cellulose or original bolt on corn mash Evolutionary biorefining with corn or cellulose feed
Retrofit (or repurposing) O t i ti h ith di t d t Opportunistic approach with distressed asset High return, low cap-ex equipment rework solution
© Green Biologics Inc. 2013 Private and Confidential 12© Green Biologics Inc. 2013 Private and Confidential
Ethanol Bolt on RelationshipEthanol Bolt on Relationship
GBL Fermentation
GBL Distillation
nol
GBL Solids & Evaporation B
utan
ol&
Ace
tone
Eth
an
Condensate
p
GBL Butanol
© Green Biologics Inc. 2013 Private and Confidential 13© Green Biologics Inc. 2013 Private and Confidential
GBL Butanolstorage & loadout
Protein solids to DDGS
Bolt on Scope Phase 1Thin Stillage
Ethanol Bolt on With CelluloseEthanol Bolt on With Cellulose
GBL FermentationPretreat to monomer sugars
Biomass Receiving and storage
Cellulose Scope Phase 2
GBL Distillation
nol
GBL Solids & Evaporation B
utan
ol&
Ace
tone
Eth
an
Condensate
p
GBL Butanol
© Green Biologics Inc. 2013 Private and Confidential 14© Green Biologics Inc. 2013 Private and Confidential
GBL Butanolstorage & loadout
Protein solids to DDGS
Bolt on Scope Phase 1Thin Stillage
Ethanol RetrofitEthanol Retrofit
Repurpose design for
butanol fermentationR
Clostridia
Sugar/Starch
fermentationRepurpose storage and
loadout
ButanolDDGS
Not Required
Repurpose for butanol
(Corn)
© Green Biologics Inc. 2013 Private and Confidential 15© Green Biologics Inc. 2013 Private and Confidential
Acetone & ethanol
Pulp and Paper OptionsPulp and Paper Options
Bolt on to existing Pulp and Paper asset Ease of deployment Value added to existing asset with upgrade of C5 sugars to
chemicals Transformation to a biorefining complex
Phase 2 addition of full cellulose conversion Fermentation including both C5 and C6 sugars Proven on wide range of cellulosic feedstocksg Evolutionary biorefining with cellulose feed Increase utilization of wood supply chain resources
© Green Biologics Inc. 2013 Private and Confidential 16© Green Biologics Inc. 2013 Private and Confidential
R&D, Pilot Plant and Demonstration Facilities,
Gahanna Pilot PlantMilton Park Labs & Pilot Plant
150 liter 2 @ 550 liter100 - 200 literBench Scale
Commercial DemonstrationDemonstration Plant
4 @ 40 000 liter Commercial Scale
© Green Biologics Inc. 2013 Private and Confidential 17© Green Biologics Inc. 2013 Private and Confidential
4 @ 40,000 liter Commercial Scale
Summary: Why Green BiologicsSummary: Why Green Biologics
Attractive markets Greater than 3.4 million tonne chemical market Renewable chemical trends Supply cost competitively (i.e. no subsidy needed)
Leadership Established commercial and technical expertise World leader in ABE fermentation technology Understanding of the chemical markets
T h l ff lti l f d t k ti Technology offers multiple feedstock options C5 & C6 sugars conversion Proven on wide range of cellulosic feedstock Extensive microbial culture collection
Attractive & capital efficient implementation options Process designs for “bolt on” & retrofit Demonstrated technology
© Green Biologics Inc. 2013 Private and Confidential 18© Green Biologics Inc. 2013 Private and Confidential
Advanced technology directed toward low cost position